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AB/BA Crossover Trials - Binary Outcome 
James F. Reed III 
Interim Chief of Health Studies and Director of Research 
Lehigh Valley Hospital and Health Network 
 
 
On occasion, the response to treatment in an AB/BA crossover trial is measured on a binary variable - 
success or failure. It is assumed that response to treatment is measured on an outcome variable with (+) 
representing a treatment success and a (-) representing a treatment failure. Traditionally, three tests for 
comparing treatment effect have been used (McNemar’s, Mainland-Gart, and Prescott’s). An issue arises 
concerning treatment comparisons when there may be a residual effect (carryover effect) of a previous 
treatment affecting the current treatment. A general consensus as to which procedure is preferable is 
debatable. However, if both group and carry-over effects are absent, Prescott’s test is the best one to use. 
Under a model with residual effects, Prescott’s test is biased. Therefore, a conservative approach includes 
testing for residual effects. When there is no period effect, McNemar’s test is optimal, while McNemar’s 
test is biased. 
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Introduction 
 
In a classic binary crossover trial, 
patients are randomly assigned to receive either 
treatment A (τA) in the first period followed by 
treatment B (τB) in a second period, or treatment 
B in the first period followed by treatment A in 
the second period. On occasion, the response to 
treatment is measured on a binary variable - 
success or failure. In a crossover design each 
subject acts as their own control, which is 
valuable in the presence of substantial between 
subject variability. The purpose of the crossover 
trial is to estimate the treatment contrast τA - τB. 
Period effects, π1 and π2, as well as carryover 
effects,  λA  and  λB,  are   regarded  as  nuisance  
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parameters. Traditionally, three tests for 
comparing treatment effect have been used 
(McNemar’s, Mainland-Gart, and Prescott’s). 
An issue arises concerning treatment 
comparisons when there may be a residual effect 
(carryover effect) of a previous treatment 
affecting the current treatment. Any residual 
effect, positive or negative, can bias the estimate 
of treatment effect. The best way of dealing with 
a potential residual effect is to design the study 
so that a suitable washout period is included so 
that the effect of the first period treatment does 
not affect the treatment applied to the second 
treatment period. If the researchers cannot safely 
insure this, then the crossover design is not an 
appropriate design.  
 
Numerical Methods 
For a binary crossover trial, assume that 
the response data may be arranged as shown in 
Table 1. Here the response to treatment is 
measured on an outcome variable with (+) 
representing a treatment success and a (-) 
representing a treatment failure. 
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Mainland - Gart Ho: {(τB - τA) = 0 and (λA - λB) 
= 0} 
Gart (1963) gave a rigorous description 
of two procedures which had been proposed 
earlier by Mainland (1963) that simultaneously 
considers the hypothesis Ho: {(τB - τA) = 0 and 
(λA - λB) = 0}. The first, an exact test, is the 
product of two symmetric binomial variables, 
while the second is a goodness-of-fit χ2 with 2 
degrees of freedom for large n’s (Table 2a). 
 
X2Ho = [(n12 - m12)2/(n12 + m12)] + [(m21 - 
n21)2/(m21 + n21)] 
  
Rejection of X2Ho indicates that there is some 
deviation from the null hypothesis in either or 
both of the components of the two-sided 
hypothesis. 
 
Gart, Fleiss Hoλ: λA - λB = 0 
Gart (1963) described an exact test and a 
normal deviate test statistic for order or carry-
over effect (δ) (e.g. Hoλ: λA - λB = 0). The exact 
test corresponds to Fisher’s Exact test for a 2 x 2 
table with fixed marginals given in Table 2b. 
The normal deviate test statistic (ZGλ) is 
defined as:  
 
ZGλ = {|n12 - ((n12+m12)(n12+m21)/M) | - 
1/2}/{[(n12+m12)(n21+m21)(n12+n21)(M-n12-
m21)]/[M2(M-1)]1/2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fleiss (1986) also described a statistic 
(X2λ) for testing the hypothesis of equal residual 
effects (Hoλ: λA - λB = 0). Let P1 = (2n11 + n12 + 
n21)/2n..., P2 = (2m11 + m12 + m21)/2m.. , V(P1) = 
1/4n3.. (n..[n12 + n22] - [n11 - n22]2), and V(P2) = 
1/4m3.. (m..[m12 + m22] - [m11 - m22]2), then 
 
X2λ is: X2λ = ( | P1 - P2 | - 1/4 (1/n.. + 1/m..))2 / 
(V(P1) + V(P2)). X2λ 
 
 is compared to a χ2 distribution with 1 degree of 
freedom.  
 
Gart, Prescott, Fleiss Hoτ: {τB - τA = 0} 
The hypothesis of the equality of 
treatment effects (τ) between the two groups 
may be tested by one of several procedures. Gart 
proposed a one-tail exact test (Fisher’s exact test 
applied to a 2 x 2 - Table 2a) and a normal 
deviate with a continuity correction when the 
sample size is large (ZGτ) (Gart, 1963). 
 
ZGτ = {|n12 - ((n12+m12)(n12+n21)/M) | - 
1/2}/{[(n12+m12)(n21+m21)(n12+n21)(M-n12-
n21)]/[M2 (M-1)]1/2. 
 Prescott (1981) derived a normal deviate 
test statistic (ZP) for testing Hoτ: {τB - τA = 0} 
(Table 3). ZP = ( |T - E(T)| - 1/2)/V(T), where: T 
= n12 - m12, E(T) = n.1 (n1. - n3. )/n.. , and V(T) = 
n.1 n.2 {(n1. - n3. ) - (n1. - n3. )2/n..}/{n.. (n.. - 1)}. 
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Table 1. Data layout for a two-period crossover with a binary response variable. 
       AB         BA 
             
 
   π2 Response    π2 Response   
             
 
π1 Response + - Total  π1 Response + - Total  
             
 + n11 n12 n1.   + m11 m12 m1. 
 
 - n21 n22 n2.   - m21 m22 m2. 
 
Total  n.1 n.2 n..  Total  m.1 m.2 m.. 
 
 
 
Table 2. Classification of binary outcomes by period preference (Mainland-Gart Test). 
 
a) Test Hoτ: {τB - τA = 0} 
           
 
        Preference 
 
Sequence Period 1 (π1)  Period 2 (π2)  Total 
           
 
 AB  n12   n21   n12 + n21 
 
 BA  m12   m21   m12 + m21 
  
Total  n12 + m12  n21 + m21  M 
 
 
b) Test Hoδ : {λA - λB = 0} 
           
 
        Preference 
 
Sequence Period 1 (π1)  Period 2 (π2)  Total 
           
 
 AB  n12   m21   n12 + m21 
 
 BA  m12   n21   m12 + n21 
  
Total  n12 + m12  n21 + m21  M 
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Fleiss (1986) describes a statistic (ZFτ) 
that tests the hypothesis of equal treatment 
effects (Hoλ: λA - λB = 0). Let p’A = n12/n’, n’ = 
n12 + n21, p’B = m12/m’, m’ = m12 + m21, p’ = (n12 
+ m12)/(n’ + m’), then ZFτ = {[| p’A - p’B| - ½ 
(1/n’ + 1/m’)]/sqrt(p’ (1 - 
p’)}/sqrt(n’m’/(n’+m’)). The hypothesis of equal 
treatment effects is rejected if ZFτ > zα/2. 
 
 
 
 
 
 
 
 
Fleiss Hoτ|λ 
 If there were a significant residual 
effect, the general advice is that the appropriate 
test for testing Hoτ|λ is to use data from the first 
treatment period. In this case Hoτ|λ may tested 
using the following test statistic (Zτ|λ) described 
by Fleiss (1986). Zτ|λ = {|pA - pB| - [1/n.. + 
1/m’)/2] / (p’ (1 - p)1/2}(n..m../(n..+ m..))1/2., 
with pA = n1./n.. , pB = m1./m.., and p’ = (n1. + 
m1.)/(n.. + m..). Hoτ|λ is rejected if Zτ|λ > Zα/2. 
 
 
 
 
 
 
 
Example 
Consider the data given by Fleiss (1986, pg 277). 
 
       AB         BA     
   π2 Response    π2 Response    
 
π1 Response + - Total  π1 Response + - Total  
             
 + 25 15 40   + 30 0 30 
 
 - 5 5 10   - 5 15 20 
 
Total  30 20 50  Total  35 15 50 
 
 
The test statistics are: Ho: {τA = τB, λA = λB} 
Mainland-Gart chi-square = 6.00, p-value = 0.04841 
 
Ho: {λA = λB} 
Mainland-Gart  E (1-tail),  p-value = 0.29181 
Mainland-Gart  Z = 0.61,  p-value = 0.54029 
Fleiss     X2 = 0.26,  p-value = 0.61914 
 
Ho: {τA = τB} 
Mainland-Gart  E (1-tail),  p-value = 0.00474 
Mainland-Gart  Z = 2.50,  p-value = 0.00621 
Prescott    Z = 2.92,  p-value = 0.00349 
Fleiss     Z = 2.55,  p-value = 0.01072 
 
Ho: {τA|λ = τ B|λ} 
Fleiss-T|Residual = 1.96,  p-value = 0.04953 
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The simultaneous test of Ho: {τA = τB, 
λA = λB} indicates that there is a difference in 
treatment effects or that there is a significant 
residual effect (or both). All of the test statistics 
and associated p-values associated with Ho: {λA 
= λB} are not statistically significant at any 
reasonable level. Further, the hypothesis Ho: {τA 
= τB} is also significant (0.01072). 
 
Discussion 
 Traditionally, three tests for comparing 
treatment effect have been used to analyze data 
from a binary two period crossover trial 
(McNemar, Mainland-Gart, and Prescott). 
McNemar’s test in effect ignores information on 
periods and tests for difference between 
expected values of n21 + m12 and n12 + m21. The 
Mainland-Gart test is Fisher’s exact test applied 
to a 2 x 2 table (Table 2). Prescott’s test expands 
the Mainland-Gart test by using tied responses 
and is a test for linear trend in a 2 X 3 table 
(Table 3).  
Other models have been proposed to 
analyze binary data from a two period crossover 
trial. For instance, Becker and Balagtas (1993) 
proposed a model in terms of linear models for 
marginal logits and linear models for log-odds 
ratios for the analysis of two-period binary 
crossover trials. Their simulation results 
demonstrated that their likelihood ratio approach 
compared favorably with standard procedures 
such as the Mainland-Gart test for a treatment 
difference, Prescott’s test for a treatment  
 
difference and the Hills-Armitage test for 
treatment by period interaction.  
Which, if any, of the procedures is best 
has been debated for nearly 40 years and the 
debate will probably continue. A general 
consensus is that if both group and carry-over 
effects are absent, Prescott’s test is the best one 
to use. Under the model with residual effects, 
Prescott’s test is biased, as it can give p-values 
that are too high or too low (Fidler, 1984). 
Estimates of treatment effects are biased when 
residual effects are present. With positive 
residual effects, the treatment effect is 
underestimated and the crossover test is 
conservative; with negative residual effects, the 
treatment effect is overestimated and the 
crossover test is liberal (Lehmacher, 1991). 
Unlike the group effect, the residual effect 
cannot be eliminated by randomization alone. 
Therefore, a conservative approach includes 
testing for residual effects. A non-significant 
result from the residual effect and external 
evidence for the absence of a residual effect is 
essential when using Prescott’s test. When there 
is no period effect, McNemar’s test is optimal, 
while McNemar’s test is biased (Fidler, 1984). 
When a crossover trial has been properly 
designed, it remains a powerful instrument in the 
analysts’ toolbox and is a reasonable and 
sensitive means of determining the efficacy of 
two treatment regimens (Cleophas & Val Lier, 
1996).  
 
 
 
Table 3. Classification of binary outcomes by period preference, including tied responses (Prescott’s 
Test). 
Test Hoτ: {τB - τA = 0} 
            
        Preference 
 
Sequence Period 1 (π1) Tied  Period 2 (π2)  Total  
            
 
 AB  n12  n11 + n22  n21   n1. 
 
 BA  m12  m11 + m22 m21   n2. 
 
 Total  n.1  n.2  n.3   n.. 
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Program 
 An executable program that produces 
the statistics outlined in this article is available 
from the author on request. The input file is in 
free format (sequence AB=1, BA=2; observation 
1, 2, n, 1, 2, m; period 1 outcome (1 = success, 0 
= failure); period 2 outcome (1 = success, 0 = 
failure). Data must be in an integer format. 
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